In This Section

Career Center

Job Seekers, Welcome to ASPET Career Center
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Search Results: 193 Jobs
Save Agent
Loading... Please wait.
UB Jacobs School and Biomedical Sciences Logo
UB Jacobs School and Biomedical Sciences

Buffalo, New York

University of Manitoba Logo
University of Manitoba

Winnipeg, Manitoba, Canada

Rutgers University - Robert Wood Johnson Medical School

Piscataway, New Jersey

The Medical College of Wisconsin, Inc Logo
The Medical College of Wisconsin, Inc

Milwaukee, Wisconsin

Foundation Health Partners Logo
Foundation Health Partners

Fairbanks, Alaska

NEW! NEW!
Stanford Children's Health - Lucile Packard Children's Hospital Logo
Stanford Children's Health - Lucile Packard Children's Hospital

Palo Alto, California

NEW! NEW!
Vanderbilt Health Logo
Vanderbilt Health

Nashville, Tennessee

NEW! NEW!
Nicklaus Children’s Health System Logo
Nicklaus Children’s Health System

Miami, Florida

NEW! NEW!
Vanderbilt Health Logo
Vanderbilt Health

Nashville, Tennessee

NEW! NEW!
NEW! NEW!
NEW! NEW!
Vanderbilt Health Logo
Vanderbilt Health

Nashville, Tennessee

NEW! NEW!
AdventHealth Logo
AdventHealth

Daytona Beach, Florida

NEW! NEW!
Stanford Children's Health - Lucile Packard Children's Hospital Logo
Stanford Children's Health - Lucile Packard Children's Hospital

Palo Alto, California

NEW! NEW!
Nemours Logo
Nemours

Wilmington, Delaware

Nemours Logo
Nemours

Wilmington, Delaware

Nemours Logo
Nemours

Wilmington, Delaware

Duke University Health System Logo
Duke University Health System

Durham, North Carolina

NEW! NEW!
Harris Health System Logo
Harris Health System

Houston, Texas

Loading... Please wait.
Associate Director Preclinical Toxicology
CompanyActinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing radiopharmaceutical therapeutics for the treatment of disease, particularly cancer. Our Antibody Radiation-Conjugates (ARCs) combine the tumor targeting ability of antibodies with the cell killing ability of radiation. Notably, Actinium possesses proprietary expertise and know-how for the development of novel ARCs armed with the potent alpha emitting radionuclide warhead Actinium-225 (225Ac). With our technology and our development capabilities, we are advancing a multi-disease, multi-target pipeline of preclinical and clinical-stage ARCs for targeted conditioning and as therapeutics for the treatment of hematologic malignancies and solid tumors. Building on our expertis


This job listing is no longer active.

Check the left side of the screen for similar opportunities.
Loading. Please wait.
Powered By Naylor Association Solutions